April 1, 2025 | Don't Stop the Beat! What is the Relationship Between Cardiovascular Risk and Prescribed Stimulants in People with ADHD? | ME SUD Learning Community

April 1, 2025 | Don’t Stop the Beat! What is the Relationship Between Cardiovascular Risk and Prescribed Stimulants in People with ADHD? | ME SUD Learning Community

$0.00

Categories: , ,

Description

April 1, 2025 | 12:00-1:00 PM

Description:

This guided discussion will begin with a description of findings from key trials published in the last five years regarding association between prescribed stimulant use and risk of cardiovascular disease, acute coronary syndrome, heart failure, hypertension, arterial disease, venous thromboembolism and arrhythmias. We will dive into the data regarding how CV risk of stimulant use compares with risk of ADHD treatment with nonstimulant medications. Finally, we will identify how findings differ based on patient population including age, sex, preexisting cardiovascular disease, and duration of stimulant use. This session will be a guided discussion rather than a typical powerpoint presentation so we will spend the majority of the session discussing what the data means and how it can be applied to optimize patient care in an individualized and patient centered fashion.

Learning Objectives:

  1. Describe findings from key trials published in the last five years regarding association between prescribed stimulant use and risk of cardiovascular disease, acute coronary syndrome, heart failure, hypertension, arterial disease, venous thromboembolism and arrhythmias.
  2. Describe how CV risk of stimulant use compares with risk of ADHD treatment with nonstimulant medications
  3. Detail how findings differ based on patient population including age, sex, preexisting cardiovascular disease, and duration of stimulant use.

Presenters:

Stephanie Nichols, PharmD, BCPP, MPH is an Associate Professor in the University of New England College of Pharmacy, Adjunct Clinical Assistant Professor of Psychiatry in the Tufts University School of Medicine, and a Psychiatric and Substance Use Disorder (SUD) Pharmacist at Maine Medical Center in Portland. She graduated from the University at Buffalo with her Doctor of Pharmacy degree and completed an Inpatient Pharmacy Practice Residency at Maine Medical Center. Dr. Nichols is dual board certified as a Pharmacotherapy Specialist (BCPS) and a Psychiatric Pharmacist (BCPP) and is a fellow of the American College of Clinical Pharmacy (FCCP).

 

Audience:

Prescribing Clinicians and their teams

Continuing Medical Education:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Hanley Center for Health Leadership and Education and CCSME. The Hanley Center for Health Leadership and Education is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.

The Hanley Center for Health Leadership and Education designates this regularly scheduled series for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

*Nurses and Nurse Practitioners will be awarded a certificate of participation with a maximum of 1 AMA PRA Category 1 Credit ™.

Contact Hours

1 contact hours for social workers, licensed clinical professional counselors, and behavioral health professionals.

1 Category 1 Contact hours for psychologists. CCSME is a pre-approved sponsor and provider of Professional Education Activities for Psychologists.

1 contact hours for Alcohol and Drug Counselors pending approval by the Maine Board of Alcohol and Drug Counselors

1 contract hours CHES. CCSME is a designated provider of continuing education contact hours (CECH) in health education by the National Commission of Health Education Credentialing, Inc.

 

Related products